127 related articles for article (PubMed ID: 17532558)
1. Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells.
Malki S; Bibeau F; Notarnicola C; Roques S; Berta P; Poulat F; Boizet-Bonhoure B
Cancer Lett; 2007 Oct; 255(2):182-93. PubMed ID: 17532558
[TBL] [Abstract][Full Text] [Related]
2. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of sox9 in ovarian Sertoli cell tumors and other tumors in the differential diagnosis.
Zhao C; Bratthauer GL; Barner R; Vang R
Int J Gynecol Pathol; 2007 Jan; 26(1):1-9. PubMed ID: 17197889
[TBL] [Abstract][Full Text] [Related]
4. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.
Drivdahl R; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Plymate SR
Oncogene; 2004 Jun; 23(26):4584-93. PubMed ID: 15077158
[TBL] [Abstract][Full Text] [Related]
5. Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination.
Wilhelm D; Martinson F; Bradford S; Wilson MJ; Combes AN; Beverdam A; Bowles J; Mizusaki H; Koopman P
Dev Biol; 2005 Nov; 287(1):111-24. PubMed ID: 16185683
[TBL] [Abstract][Full Text] [Related]
6. Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells.
Eichele K; Ramer R; Hinz B
Oncogene; 2008 May; 27(21):3032-44. PubMed ID: 18071320
[TBL] [Abstract][Full Text] [Related]
7. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).
Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH
J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162
[TBL] [Abstract][Full Text] [Related]
8. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.
Fujimori K; Fukuhara A; Inui T; Allhorn M
J Neurochem; 2012 Jan; 120(2):279-91. PubMed ID: 22043816
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin D synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ.
Fukuoka T; Yashiro M; Kinoshita H; Morisaki T; Hasegawa T; Hirakawa T; Aomatsu N; Takeda H; Maruyama T; Hirakawa K
Int J Cancer; 2015 Sep; 137(5):1235-44. PubMed ID: 25516376
[TBL] [Abstract][Full Text] [Related]
10. Male specific expression of lipocalin-type prostaglandin D synthase (cPTGDS) during chicken gonadal differentiation: relationship with cSOX9.
Moniot B; Boizet-Bonhoure B; Poulat F
Sex Dev; 2008; 2(2):96-103. PubMed ID: 18577876
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
12. Role of hedgehog signaling in ovarian cancer.
Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
[TBL] [Abstract][Full Text] [Related]
13. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products.
Kim J; Yang P; Suraokar M; Sabichi AL; Llansa ND; Mendoza G; Subbarayan V; Logothetis CJ; Newman RA; Lippman SM; Menter DG
Cancer Res; 2005 Jul; 65(14):6189-98. PubMed ID: 16024620
[TBL] [Abstract][Full Text] [Related]
14. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
Vidal VP; Ortonne N; Schedl A
J Cutan Pathol; 2008 Apr; 35(4):373-9. PubMed ID: 18333897
[TBL] [Abstract][Full Text] [Related]
15. Diminished lipocalin-type prostaglandin D(2) synthase expression in human lung tumors.
Ragolia L; Palaia T; Hall CE; Klein J; Büyük A
Lung Cancer; 2010 Oct; 70(1):103-9. PubMed ID: 20144489
[TBL] [Abstract][Full Text] [Related]
16. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
[TBL] [Abstract][Full Text] [Related]
17. [Construction and identification of small interfering RNA expression plasmid targeting Sox9 and the function to cell growth and apoptosis of human chondrosarcoma cells HTB94].
Qin HM; Han HF; Xu T; Sha GZ; Liu L; Peng YG; Ren TC
Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):772-5. PubMed ID: 18953935
[TBL] [Abstract][Full Text] [Related]
18. SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development.
Wilhelm D; Hiramatsu R; Mizusaki H; Widjaja L; Combes AN; Kanai Y; Koopman P
J Biol Chem; 2007 Apr; 282(14):10553-60. PubMed ID: 17277314
[TBL] [Abstract][Full Text] [Related]
19. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis.
Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E
Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788
[TBL] [Abstract][Full Text] [Related]
20. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
